A rationale for delivery of osteoinductive proteins

Tissue Engineering

Volumn 2, Issue 2, 1996, Pages 97-114

  Brekke, John H ^a  

^a THM Biomedical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

BONE GRAFT; BONE REGENERATION; BONE TISSUE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; WOUND HEALING;

EID: 0029940398     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1996.2.97     Document Type: Review

References (131)

1. Hollinger, J.O., Brekke, J.H., Gruskin, E., and Lee, D. Role of bone substitutes. Clin. Orthop. 324, 55, 1996.
2. Smith, J.L., Jin, L., Parsons, T., Turek, T., Ron, E., Philbrook, C.M., Kenley, R.A., Marden, L., Hollinger, J., Bostrom, M.P.G., Tomin, E., and Lane, J.M. Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2). J. Controlled Release 36, 183, 1995.
3. Schimandle, J.H., Boden, S.D., and Hutton, W.C. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20(12), 1326, 1995.
4. Reddi, A.H., and Cunningham, N.S. Recent progress in bone induction by osteogenin and bone morphogenetic proteins: Challenges for biomechanical and tissue engineering. J. Biomech. Eng. 113, 189, 1991.
5. Toriumi, D.M., East, C.A., and Larrabee, W.F. Osteoinductive biomaterials for medical implantation. J. Long-Term Effects Med. Implant. 1(1), 53, 1991.
6. Toriumi, D.M., Kotler, H.S., Luxenberg, D.P., Holtrop, M.E., and Wang, E.A. Mandibular reconstruction with a recombinant bone-inducing factor. Arch. Otolaryngol. Head Neck Surg. 117, 1101, 1991.
7. Hollinger, J., and Chaudhari, A. Bone regeneration materials for the mandibular and craniofacial complex. Cells Materials 2(2), 143, 1992.
8. Hollinger, J. Strategies for regenerating bone of the craniofacial complex. Bone 14, 575, 1993.
9. Hollinger, J. Factors for osseous repair and delivery: Part II. J. Craniofacial Surg. 4(3), 135, 1993.
10. Kenley, R.A., Yim, K., Abrams, J., Ron, E., Turek, T., Marden, L.J., and Hollinger, J.O. Biotechnology and bone graft substitute. Pharmaceut. Res. 10(10), 1393, 1993.
11. Ripamonti, U., Yeates, L., and van den Heever, B. Initiation of heterotopic osteogenesis in primates after Chromatographic adsorption of osteogenin, a bone morphogenetic protein, onto porous hydroxyapatite. Biochem. Biophys. Res. Commun. 193(2), 509, 1993.
12. Ripamonti, U., and Reddi, A.H. Periodontal regeneration: Potential role of bone morphogenetic proteins. J. Periodont. Res. 29, 225, 1994.
13. Ripamonti, U., and Vukicevic, S. Bone morphogenetic proteins: From developmental biology to molecular therapeutics. S. Afr. J. Sci. 91, 277, 1995.
14. Breitbart, A.S., Staffenberg, D.A., Thorne, C.H.M., Glat, P.M., Cunningham, N.S., Reddi, A.H., Ricci, J., and Steiner, G. Tricalcium phosphate and osteogenin: A bioactive onlay bone graft substitute. Plast. Reconstr. Surg. 96(3), 699, 1995.
15. Kirker-Head, C.A., Gerhart, T.N., Schelling, S.H., Hennig, G.E., Wang, E., and Holtrop, M.E. Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clin. Orthop. 318, 222, 1995.
16. Boden, S.D., Schimandle, J.H., and Hutton, W.C. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 20(24), 2633, 1995.
17. Brekke, J.H. Architectural principles applied to three-dimensional therapeutic implants composed of bioresorbable polymers. In Wise, D., et al., eds., Encyclopedic Handbook of Biomaterials and Bioengineering, Vol. 1. New York: Marcel Dekker, 1995, pp. 689-731.
18. Wang, E.A., Israel, D.I., Kelly, S., and Luxenberg, D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9, 57, 1993.
19. Ahrens, M., Ankenbauer, T., Schröder, D., Hollnagel, A., Mayer, H., and Gross, G. Expression of human bone morphogenetic protein-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 12(10), 871, 1993.
20. Asahina, I., Sampath, T.K., and Hauschka, P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic and/or adipocytic differentiation of clonal murine target cells. Exp. Cell Res. 222, 1996.
21. Beresford, J.N. Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. 240, 270, 1989.
22. Poliard, A., Nifuji, A., Lamblin, D., Plee, E., Forest, C., and Kellermann, O. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways. J. Cell Biol. 130(6), 1461, 1995.
23. Urist, M.R. Bone: Formation by autoinduction. Science 150, 893, 1965.
24. Urist, M.R., Hay, P.H., Dubuc, F., and Buring, K. Osteogenic competence. Clin. Orthop. 64, 194, 1969.
25. Urist, M.R., Iwata, H., Ceccotti, P.L., Dorfman, R.L., Boyd, S.D., McDowell, R.M., and Chien, C. Bone morphogenesis in implants of insoluble bone gelatin. Proc. Natl. Acad. Sci. U.S.A. 70, 3511, 1973.
26. Urist, M.R., Granstein, R., Nogami, H., Svenson, L., and Murphy, R. Transmembrane bone morphogenesis across multiple-walled diffusion chambers. Arch. Surg. 112, 612, 1977.
27. Urist, M.R., Lietze, A., Mizutani, H., Takagi, K., Triffitt, J.R., et al. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin. Orthop. 162, 219, 1982.
28. Wozney, J. Bone morphogenetic proteins. Progr. Growth Factor Res. 1, 267, 1989.
29. Lyons, K.M., Pelton, R.W., and Hogan, B.L.M. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes & Dev. 3, 1657, 1989.
30. Lyons, K.M., Pelton, R.W., and Hogan, B.L.M. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109, 833, 1990.
31. Vainio, S., Karavanova, I., Jowett, A., and Thesleff, I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 75, 45, 1993.
32. Kingsley, D.M. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Gent. 10(1), 16, 1994.
33. Wozney, J.M. Bone morphogenetic proteins and their gene expression. In Noda, M. ed., Cellular and Molecular Biology of Bone. San Diego: Academic Press, 1993, pp. 132-167.
34. Wang, E.A. Bone morphogenetic proteins in differentiation. Fourth Int. Conf. Mol. Biol. Pathol. Matrix. Matrix 13(1), 1993.
35. Ogata, T., Wozney, J.M., Rodan, G.A., and Noda, M. Bone morphogenetic protein-2 (BMP-2) acts both synergistically with and antogonistically against retinoic acid in regulating expression of phenotypic genes in osteoblast-like cells. Endocrine J. 2 237, 1994.
36. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., and Cordes, P., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 87, 2220, 1990.
37. Caplan, A., Fink, D.J., Goto, T., Linton, A.B., Young, R.G., Wakitani, S., Goldberg, V.M., and Haynesworth, S.E. Mesenchymal stem cells and tissue repair. In Jackson, D.W. et al., eds., The Anterior Crucitate Ligament: Current and Future Concepts. New York: Raven Press, 1993, pp. 405-417.
38. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell. Biochem. 56, 283, 1994.
39. Nogami, H., and Urist, M.R. A substratum of bone matrix for differentiation of mesenchymal cells into chondroosseous tissues in vitro. Exp. Cell Res. 63, 404, 1970.
40. Urist, M.R., Sato, K., Brownell, A.G., Malinin, T.I., Lietze, A., et al. Human bone morphogenetic protein (hBMP). Proc. Soc. Exp. Biol. Med. 173, 194, 1983.
41. Urist, M.R., DeLange, R., and Finerman, G.A.M. Bone cell differentiation and growth factors. Science 220, 680, 1983.
42. Scutt, A., Mayer, H., and Wingender, E. New perspectives in the differentiation of bone-forming cells. BioFactors 4(1), 1992.
43. Young, H.E., Ceballos, E.M., Smith, J.C., Mancini, M.L., Wright, R.P., et al. Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell. Dev. Biol. 29A, 723, 1993.
44. Young, H.E., Mancini, M.L., Wright, R.P., Smith, J.C., Black, A.C., Jr., Reagan, C.R., and Lucas, P.A. Mesenchymal stem cells reside within the connective tissues of many organs. Dev. Dynam. 202, 137, 1995.
45. Urist, M.R., and Hudak, R.T. Radioimmunoassay of bone morphogenetic protein in serum: A tissue-specific parameter of bone metabolism. Proc. Soc. Exp. Biol. Med. 176, 472, 1984.
46. Kaplan, F., and Shore, E.M. Bone morphogenetic proteins and c-FOS: Early signals in endochondral bone formation: Portland Bone Symposium - 1995, 44-64.
47. Owen, M. Lineage of osteogenic cells and their relationship to the stromal system. In Peck, W.A., ed., Bone and Mineral Research, Vol. 3. Amsterdam: Elsevier Science Publishers B.V., 1985, pp. 1-25.
48. Mathieu, E., Schoeters, G., Plaetse, F.V., and Merregaert, J. Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus. Calcif. Tissue Int. 50, 362, 1992.
49. Bennett, J.H., Joyner, C.J., Triffitt, J.T., and Owen, M.E. Adipocytic cells cultured from marrow have osteogenic potential. J. Cell Sci. 99(Part 1), 131, 1991.
50. Berry, L., Grant, M.E., McClure, J., and Rooney, P. Bone-marrow-derived chondrogenesis in vitro. J. Cell Sci. 101, 333, 1992.
51. Vilamitjana-Amedee, J., Bareille, R., Rouais, F., Caplan, A.I., and Harmand, M-F. Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev. Biol. 29A, 699, 1993.
52. Dorheim, M-A., Sullivan, M., Dandapani, V., Wu, X., Hudson, J., et al. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J. Cell. Phys. 154, 317, 1993.
53. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 84(12), 4164, 1994.
54. Troup, S.B., and Schwartz, S.I. Hemostasis, surgical bleeding, and transfusion. In Schwartz, S.I., ed., Principles of Surgery. New York: McGraw-Hill, 1969, pp. 105-107.
55. Urist, M.R. New bone formation induced in postfetal life by bone morphogenetic protein. In Becker, R.O., ed., Mechanisms of Growth Control. Springfield, IL: Charles C Thomas, 1981, pp. 406-434.
56. Lewis, D.H. Controlled release of bioactive agents from lactide/glycolide polymers. In Chasin, M., and Langer, R., eds. Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker, 1990, pp. 1-41.
57. Hollinger, J.O., Jamiolkowski, B.S., and Shalaby, S.W. Bone repair and a unique class of biodegradable polymers: The poly(α-esters). In Hollinger, J.O., ed., Biomedical Applications of Synthetic Biodegradable Polymers. Boca Raton, FL: CRC Press, 1995, pp. 197-222.
58. von Schroeder, H.P., Kwan, M., Amiel, D., and Coutts, R.D. The use of polylactic acid matrix and periosteal grafts for the reconstruction of rabbit knee articular defects. J. Biomed. Mater. Res. 25, 329, 1991.
59. Chu, D.R., Coutts, R.D., Yoshioka, M., Harwood, F.L., Monosov, A.Z., and Amiel, D. Articular cartilage repair using allogeneic perichondrocyte-seeded biodegradable porous polylactic acid (PLA): A tissue-engineering study. J. Biomed. Mater. Res. 29, 1147, 1995.
60. Chu, C.R., Monosov, A.Z., and Amiel, D. In situ assessment of cell viability within biodegradable polylactic acid polymer matrices. Biomaterials 16(18), 1381, 1995.
61. Olson, R.A.J., Roberts, D.L., and Osbon, D.B. A comparative study of polylactic acid, gelfoam, and surgicel in healing extraction sites. Oral Surg. Oral Med. Oral Pathol. 53(5), 441, 1982.
62. Robinson, B.P., Hollinger, J.O., Szachowicz, E.H., and Brekke, J.H. Calvarial bone repair with porous D,L-polylactide. Otolaryng. Head Neck Surg. 112(6), 707, 1995.
63. Anderson, J.M. Perspectives on the in vivo responses of biodegradable polymers. In Hollinger, J.O., ed., Biomedical Applications of Synthetic Biodegradable Polymers. Boca Raton, FL: CRC Press, 1995, pp. 223-233.
64. Sandhu, H., Kanim, L., Kabo, J.M., Toth, J., Dawson, E., et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20(24), 2669, 1995.
65. Sandhu, H., Kanim, L., Kabo, J.M., Toth, J., Dawson, E., et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996. (in press).
66. Matlaga, B.F., Yasenchak, L.P., and Salthouse, T.N. Tissue response to implanted polymers: The significance of sample shape. J. Biomed. Mater. Res. 10, 391, 1976.
67. Salthouse, T.N., and Matlaga, B.F. Some cellular effects related to implant shape and surface. In Rubin, L.R., ed., Biomaterials in Reconstructive Surgery. St. Louis: C.V. Mosby, 1983, pp. 40-45.
68. Taylor, S.R. Effect of surface texture on the soft tissue response to polymer implants. J. Biomed. Mater. Res. 17, 205, 1983.
69. Behling, C.A., and Spector, M. Quantitative characterization of cells at the interface of long-term implants of selected polymers. J. Biomed. Mater. Res. 20, 653, 1986.
70. Goodman, S.B., Fornasier, V.L., and Kei, J. The effects of bulk versus particulate polymethylmethacrylate on bone. Clin. Orthop. 232, 255, 1988.
71. van Sliedregt, A., Knook, M., Hesseling, S.C., Koerten, H.K., de Groot, K., and van Blitterswijk, C.A. Cellular reaction on the intraperitoneal injection of four types of polylactide particulates. Biomaterials 13(12), 819, 1992.
72. Shanbhag, A.S., Jacobs, J.J., Black, J., Galante, J.O., and Glant, T.T. Macrophage/particle interactions: Effect of size, composition and surface area. J. Biomed. Mater. Res. 28, 81, 1994.
73. Sandhu, H.S., Kanim, L.E.A., Brekke, J.H., Smith, J.L., and Dawson, E.G., Evaluation of rh-BMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Paper #57, Scoliosis Res. Soc. 29th Annual Meeting, Portland, OR, Sept. 21-24, 1995.
74. Gilbert, S.F. Developmental Biology, 4th ed. Sunderland, MA: Sinauer Associates, 1994, pp. 231-232.
75. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J.D. Molecular Biology of the Cell, 3rd ed. New York: Garland Publishing, 1994, pp. 974-975.
76. The Biology of Hyaluronan, Ciba Foundation Symposium #143, 1989.
77. Nathanson, M.A. Hyaluronates in developing skeletal tissues. Clin. Orthop. 251, 275, 1990.
78. Shah, C.B., and Barnett, S.M. Swelling behavior of hyaluronic acid gels. J. Applied Polymer Sci. 45, 293, 1992.
79. Davis, A., Gormally, J., and Jones, E.W. A study of factors influencing hydration of sodium hyaluronate from compressibility and high-precision densimetric measurements. Biochem. J. 213, 363, 1983.
80. Laurent, T.C., and Fraser, J.R.E. Hyaluronan. FASEB 6, 2397, 1992.
81. Laurent, T.C. The interaction between polysaccharides and other macromolecules. 9. The exclusion of molecules from hyaluronic acid gels and solutions. Biochem. J. 93, 106, 1964.
82. Forrester, J.V., and Balazs, E.A.B. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40, 435, 1980.
83. Suzuki, Y., and Yamaguchi, T. Effects of hyaluronic acid on macrophage phagocytosis and active oxygen release. Agents Actions 38, 32, 1993.
84. Presti, D., and Scott, J.E. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OḢ) radicals is dependent on hyaluronan molecular mass. Cell Biochem. Funct. 12, 281, 1994.
85. Burd, D.A.R., Greco, R.M., Regauer, S., Longaker, M.T., Siebert, J.W., and Garg, H.G. Hyaluronan and wound healing: A new perspective. Br. J. Plast. Surg. 44, 579, 1991.
86. Sasaki, T., and Watanabe, C. Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid. Bone 16(1), 9, 1995.
87. Prisell, P.T., Camber, O., Hiselius, J., and Norstedt, G. Evaluation of hyaluronan as a vehicle for peptide growth factors. Int. J. Pharmaceut. 85, 51, 1992.
88. Roy, F., DeBlois, C., and Doillon, C.J. Extracellular matrix analogs as carriers for growth factors: In vitro fibroblast behavior. J. Biomed. Mater. Res. 27, 389, 1993.
89. Ghezzo, E., Benedetti, L., Rochira, M., Biviano, F., and Callegaro, L. Hyaluronan derivative microspheres as NGF delivery devices: Preparation methods and in vitro release characterization. Int. J. Pharm. 87, 21, 1992.
90. Laurent, U.B.G., Fraser, J.R.E., and Laurent, T.C. An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp. Eye Res. 46, 49, 1988.
91. Nimrod, A., Ezra, E., Ezov, N., Nachum, G., and Parisada, B. Absorption, distribution, metabolism, and excretion of bacteria-derived hyaluronic acid in rats and rabbits. J. Ocular Pharm. 8(2), 161, 1992.
92. Laurent, U.B.G., and Reed, R.K. Turnover of hyaluronan in the tissues. Adv. Drug. Deliv. Rev. 7, 237, 1991.
93. 3H]hyaluronan injected subcutaneously in rabbits. Am. J. Physiol. 259, H532, 1990.
94. Brown, T.J., Laurent, U.B.G., and Fraser, J.R.E. Turnover of hyaluronan in synovial joints: Elimination of labelled hyaluronan from knee joint of the rabbit. Exp. Physiol. 76, 125, 1991.
95. Laurent, U.B.G., Dahl, L.B., and Reed, R.K. Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp. Physiol. 76, 695, 1991.
96. Fraser, R.E., Kimpton, W.G., Laurent, R.C., Cahill, R.N.P., and Vakakis, N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J. 256, 153, 1988.
97. Yamada, K.M., Kennedy, D.W., Kimata, K., and Pratt, R.M. Characterization of fibronectin interactions with glycosaminoglycans and identification of active proteolytic fragments. J. Biol. Chem. 255(3), 6055, 1980.
98. Nakamura, M., Mishima, H., Nishida, T., and Otori, T. Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J. Cell. Physiol. 159, 415, 1994.
99. Miyake, K., Underbill, C.B., Lesley, J., and Kincade, P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172, 69, 1990.
100. Lesley, J., and Hyman, R. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 22, 2719, 1992.
101. Lesley, J., Hyman, R., and Kincade, P.W. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 271, 1993.
102. Peach, R.J., Hollenbaugh, D., Stamenkovic, I., and Aruffo, A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122(1), 257, 1993.
103. McCourt, P.A.G., Ek, B., Forsberg, N., and Gustafson, S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269(48), 30081, 1994.
104. Yang, B., Yang, B.L., Savani, R.C., and Turley, E.A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13(2), 286, 1994.
105. 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J. Cell Biol. 123(3), 749, 1993.
106. Pure, E., Camp, R.L., Peritt, D., Panettieri, R.A., Jr., Lazaar, A.L., and Nayak, S. Defective phosphorylation and haluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181, 55, 1995.
107. Sherman, L., Sleeman, J., Herrlich, P., and Ponta, H. Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol. 6, 726, 1994.
108. Underbill, C.B. Hyaluronan is inversely correlated with the expression of CD44 in the dermal condensation of the embyonic hair follicle. J. Invest. Dermatol. 101(6), 820, 1993.
109. Knudson, C., and Knudson, W. Hyaluronan-binding proteins in development, tissue hemostasis, and disease. FASEB J. 7, 1233, 1993.
110. Haegel, H., Dierich, A., and Ceredig, R. CD44 in differentiated embryonic stem cells: Surface expression and transcripts encoding multiple variants. Dev. Immun. 3, 239, 1994.
111. LeBoeuf, R.D., Raga, R.H., Fuller, G.M., and Weigel, P.H. Human fibrinogen specifically binds hyaluronic acid. J. Biol. Chem. 261, 12586, 1986.
112. LeBoeuf, R.D., Gregg, R.R., Weigel, P.H., and Fuller, G.M. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry 26, 6052, 1987.
113. Frost, S.J., and Weigel, P.H. Binding of hyaluronic acid to mammalian fibrinogens. Biochim. Biophys. Acta 1034, 39, 1990.
114. West, D.C., Hampson, I.N., Arnold, F., and Kumar, S. Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324, 1985.
115. Lees, V.C., Fan, T-P.D., and West, D.C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest. 73(2), 259, 1995.
116. Orlidge, A., and D'Amore, A. Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components. Microvasc. Res. 31, 41, 1986.
117. Caplan, A.I. Cartilage begets bone versus endochondral myelopoiesis. Clin. Orthop. 261, 257, 1990.
118. Sasano, Y., Ohtani, E., Narita, K., Kagayama, M., Murata, M., et al. BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo. Anat. Rec. 236, 373, 1993.
119. Ingber, D.E., and Folkman, J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix. J. Cell Biol. 109, 317, 1989.
120. Ingber, D. Integrins as mechanochemical transducers. Curr. Opin. Cell. Biol. 3, 841, 1991.
121. Sims, J.R., Karp, S., and Ingber, D.E. Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J. Cell Sci. 103, 1215, 1992.
122. Ingber, D.E. The riddle of morphogenesis: A question of solution chemistry or molecular cell engineering. Cell 75, 1249, 1993.
123. Traianedes, K., Ng, K.W., Martin, T.J., and Findlay, D.M. Cell substratum modulates responses of preosteoblasts to retinoic acid. J. Cell. Physiol. 157, 243, 1993.
124. Sidhu, R.S. Two-dimensional electrophoretic analysis of protein synthesized during differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 254, 11111, 1979.
125. Fernández, J.L.R., and Ben-Ze'ev, A. Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: Inhibition by extracellular matrix and polylysine. Differentia 42, 65, 1989.
126. Hikichi, Y., Sugihara, H., and Sugimoto E. Differentiation of brown adipose cells in three-dimensional collagen gel culture. Pathol. Res. Pract. 189, 73, 1993.
127. Attawia, M.A., Devin,J.E., and Laurencin, C.T. Immunofluorescence and confocal laser scanning microscopy studies of osteoblast growth and phenotypic expression in three-dimensional degradable synthetic matrices. J. Biomed. Mater. Res. 29, 843, 1995.
128. Cancedda, F.D., Gentili, C., Manduca, P., and Cancedda, R. Hypertrophic chondrocytes undergo further differentiation in culture. J. Cell Biol. 117(2), 427, 1992.
129. Hollinger, J.O., and Leong, K. Poly (α-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 17(2), 187, 1996.
130. Bell, E. Strategy for the selection of scaffolds for tissue engineering. Tissue Eng. 1(2), 163, 1995.
131. Yasemski, M.J., Payne, R.G., Hayes, W.C., Langer, R., and Mikos, A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17(2), 175, 1996.